Stocks and Investing Stocks and Investing
Thu, December 19, 2024
[ Thu, Dec 19th 2024 ] - MSN
Suze Orman: What To Invest in if You Don't Know Where To Put Your Money
[ Thu, Dec 19th 2024 ] - The Motley Fool
A TikTok Ban Would Be Great News for Meta Platforms, But It Also Highlights a Huge Risk
[ Thu, Dec 19th 2024 ] - Yahoo Finance
FTSE 100 closes lower and US rebounds following Fed rate cut scare and BoE hold
[ Thu, Dec 19th 2024 ] - bnnbloomberg
Volatility Futures Show Equities Fear Limited to Near Term
[ Thu, Dec 19th 2024 ] - MSN
Brokers Suggest Investing in Owens Corning (OC): Read This Before Placing a Bet
[ Thu, Dec 19th 2024 ] - Seeking Alpha
Beware The Return Of The S&P 500 Bubble
[ Thu, Dec 19th 2024 ] - The Globe and Mail
Down 30% From Its High, Should You Buy Uber Technologies Stock on the Dip?
[ Thu, Dec 19th 2024 ] - MSN
Best ESG ETFs: Top funds for socially responsible investing
[ Thu, Dec 19th 2024 ] - The Motley Fool
Is SoFi a Millionaire Maker?
[ Thu, Dec 19th 2024 ] - Yahoo Finance
3 Magnificent Mutual Funds to Maximize Your Retirement Portfolio
[ Thu, Dec 19th 2024 ] - The Motley Fool
3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income
[ Thu, Dec 19th 2024 ] - MSN
3 Most Upgraded Stocks Closing 2024: What's Next?
[ Thu, Dec 19th 2024 ] - MSN
Is a stock market crash coming? And what should I do now?
[ Thu, Dec 19th 2024 ] - Aviva
Types of Investments
[ Thu, Dec 19th 2024 ] - MSN
Inside ExxonMobil's $30 Billion Plan to Build the Energy Company of the Future
[ Thu, Dec 19th 2024 ] - The Motley Fool UK
2 FTSE 100 stocks that could outperform the index in 2025
[ Thu, Dec 19th 2024 ] - Bloomberg L.P.
What's Next for Five of 2024's Most Dramatic Tech Stock Stories
[ Thu, Dec 19th 2024 ] - MSN
Stock Buybacks Outperform Dividends: Here's the Key Advantage
[ Thu, Dec 19th 2024 ] - Seeking Alpha
Retirement-Ready Income: 5 Dividend Gems I'd Buy If I Were 65
[ Thu, Dec 19th 2024 ] - Seeking Alpha
Where Do Stocks Go From Here?
[ Thu, Dec 19th 2024 ] - moneycontrol.com
Super Fund Manager 2024: How this fund manager is winning the infra game with 47% return in a year
[ Thu, Dec 19th 2024 ] - MSN
Five key investing lessons for stock market investors from 2024
[ Thu, Dec 19th 2024 ] - The Globe and Mail
Investing in 2025 will be 'choose your own advent .. eveals its top TSX stock picks for the year ahead
[ Thu, Dec 19th 2024 ] - Morningstar
The 60/40 Portfolio in 2025: What to Expect
[ Thu, Dec 19th 2024 ] - Analytics Insight
Invest Wisely: Your Step-by-Step Guide on How to Invest in Stocks
[ Thu, Dec 19th 2024 ] - Business Insider
America is one big casino now
[ Thu, Dec 19th 2024 ] - Business Insider
Stocks tanked after the Fed signaled fewer rate cuts next year. Here's what analysts are saying.
[ Thu, Dec 19th 2024 ] - The Globe and Mail
Nvidia vs. Broadcom: Which Is the Better AI Chip Stock to Own in 2025?
[ Thu, Dec 19th 2024 ] - bnnbloomberg
S&P 500 Buyers Step in Ahead of Fed Meet Despite Narrow Breadth
[ Thu, Dec 19th 2024 ] - The Motley Fool
Got $250? 2 Healthcare Stocks to Buy and Hold Forever

Got $250? 2 Healthcare Stocks to Buy and Hold Forever


Published on 2024-12-19 06:21:09 - The Motley Fool
  Print publication without navigation

  • That's why Novo Nordisk's shares are worth sticking with for good, and at about $108 apiece, investors can afford two of them with $250 and have some change left over.

The article from The Motley Fool, published on December 19, 2024, discusses two healthcare stocks recommended for long-term investment with a modest investment of $200. The first stock highlighted is Teladoc Health (TDOC), which has faced challenges but is seen as a potential recovery story due to its telehealth services becoming increasingly vital in modern healthcare. Despite past setbacks, its large market opportunity and potential for profitability make it an attractive buy. The second stock is Vertex Pharmaceuticals (VRTX), known for its cystic fibrosis treatments and expanding into other rare diseases. Vertex's robust pipeline, including treatments for conditions like sickle cell disease, and its consistent financial performance, suggest strong growth potential. The article emphasizes the long-term investment perspective, suggesting that these stocks could be held indefinitely due to their growth prospects in the evolving healthcare sector.

Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/19/got-200-2-healthcare-stocks-to-buy-and-hold-foreve/ ]
Contributing Sources